Recerca

Tractament del càncer pediàtric

Buscador de publicacions

Publicacions

  • Rosabal-Obando M, Osorio DS, Lassaletta A, Morales-La Madrid A, Bartels U, Finlay JL, Qaddoumi I, Rutkowski S and Mynarek M.

    Follow-up evaluation of a web-based pediatric brain tumor board in Latin America.

    PEDIATRIC BLOOD & CANCER . 68(9): . Nº de cites: 9

    [doi:10.1002/pbc.29073]

  • Stacey AW, Bowman R, Foster A, Kivelä TT, Munier FL, Cassoux N, Fabian ID, Al Harby L, Alarcón Portabella S, Alia DB, All-Eriksson C, Antonino R, Astbury NJ, Balaguer J, Balwierz W, Barranco H, Bascaran C, Beck Popovic M, Biewald EM, Bobrova N, Bornfeld N, Brichard BG, Blum S, Capra M, Castela G, Català-Mora J, Chantada G, Chernodrinska VS, Cieslik K, Comsa C, Correa Llano MG, Csóka M, De Potter P, Desjardins L, Dragomir MD, Fernández-Teijeiro A, García Aldana D, Gregersen PA, Gomel N, Hadjistilianou T, Hederova S, Hummlen M, Husakova K, Ida R, Ilic VR, Jenkinson H, Kapelushnik N, Kardava T, Keren-Froim N, Kepak T, Khotenashvili Z, Klett A, Krivaitiene D, Latinovic S, Lumbroso L, Lysytsia L, Maka E, Martín Begue N, Midena E, Moll AC, Murgoi G, Naumenko L, Neroev V, Nikitovic M, Olechowski A, Papyan R, Parrozzani R, Parulekar MV, Pawinska-Wasikowska K, Peric S, Pochop P, Polyakov VG, Reddy MA, Ritter-Sovinz P, Saakyan S, Sagoo MS, San Román Pacheco S, Seregard S, Silva S, Sorochynska T, Stathopoulos C, Stirn Kranjc B, Svojgr K, Tamamyan G, Tandili A, Tateshi B, Tekavcic Pompe M, Urbak SF, Ushakova TL, Valeina S, van Hoefen Wijsard M, Veleva-Krasteva NV, Viksnins M, Wackernagel W, Wolley Dod C, Yarovaya VA, Yarovoy AA, Zhilyaeva K, Zondervan M and Global Retinoblastoma Study Group.

    Incidence of Retinoblastoma Has Increased: Results from 40 European Countries.

    Ophthalmology . 128(9): 1369-1371. Nº de cites: 32

    [doi:10.1016/j.ophtha.2021.01.024]

  • Pérez JPM, Muchart-Lopez J, Santa-María López V, Suñol M, Salvador-Marcos N, Pérez-Jaume S, Cruz-Martínez O and Morales-La Madrid A.

    Targeted therapy for pediatric low-grade glioma

    CHILDS NERVOUS SYSTEM . 37(8): 2511-2520. Nº de cites: 13

    [doi:10.1007/s00381-021-05138-3]

  • Torres SF, Iolster T, Reyes Haczek PJ, Berro M, Longo PG, Siaba Serrate AJ, Schnitzler EJ, Chantada G and Kusminsky GD.

    Niños con trasplante de progenitores hematopoyéticos admitidos en una unidad de cuidados intensivos: análisis de la sobrevida y los factores predictivos de mortalidad.

    ARCHIVOS ARGENTINOS DE PEDIATRIA . 119(4): 230-237. Nº de cites: 3

    [doi:10.5546/aap.2021.eng.230]

  • Kebudi R, Chantada G, Kurucu N, Tugcu D, Mukkada S and C Moreira D.

    COVID-19: Consequences for Children With Cancer in Turkey and Globally.

    turkish archives of pediatrics . 56(4): 295-299. Nº de cites: 9

    [doi:10.5152/TurkArchPediatr.2021.21134]

  • Vassileva V, Braga M, Barnes C, Przystal J, Ashek A, Allott L, Brickute D, Abrahams J, Suwan K, Carcaboso AM, Hajitou A and Aboagye EO.

    Effective Detection and Monitoring of Glioma Using [18F]FPIA PET Imaging

    Biomedicines . 9(7): 811. Nº de cites: 6

    [doi:10.3390/biomedicines9070811]

  • Carrere X, Pinto N, Gene-Olaciregui N, Galluzzo L, Rossetti E, Celis-Passini V, Salvador-Marcos N, Chantada G, Braier J, Lavarino C and Felizzia G.

    High prevalence of BRAF(V600E) in patients with cholestasis, sclerosing cholangitis or liver fibrosis secondary to Langerhans cell histiocytosis

    PEDIATRIC BLOOD & CANCER . 68(7): 29115. Nº de cites: 3

    [doi:10.1002/pbc.29115]

  • Castillo H, Pascual-Pastó G, Pérez-Jaume S, Resa-Parés C, Vilà-Ubach M, Monterrubio C, Jimenez-Cabaco A, Baulenas-Farrés M, Muñoz-Aznar O, Salvador-Marcos N, Cuadrado-Vilanova M, Gene-Olaciregui N, Balaguer-Lluna L, Burgeño-Sandoval V, Vicario FJ, Manzanares-Quintela A, Castañeda-Heredia A, Santa-María López V, Cruz-Martínez O, Celis-Passini V, Morales-La Madrid A, Garraus-Oneca M, Gorostegui M, Vancells M, Carrasco-Torrents R, Krauel L, Torner-Rubies F, Suñol M, Lavarino C, Mora J and Carcaboso AM.

    Prognostic value of patient-derived xenograft engraftment in pediatric sarcomas

    JOURNAL OF PATHOLOGY CLINICAL RESEARCH . 7(4): 338-349. Nº de cites: 16

    [doi:10.1002/cjp2.210]

  • Dittner-Moormann S, Reschke M, Abbink FCH, Aerts I, Atalay HT, Fedorovna Bobrova N, Biewald E, Brecht IB, Caspi S, Cassoux N, Castela G, Diarra Y, Duncan C, Ebinger M, Garcia Aldana D, Hadjistilianou D, Kepák T, Klett A, Kiratli H, Maka E, Opocher E, Pawinska-Wasikowska K, Rascon J, Russo I, Rutynowska-Pronicka O, Sábado Álvarez C, Pacheco SSR, Svojgr K, Timmermann B, Vishnevskia-Dai V, Eggert A, Ritter-Sovinz P, Bechrakis NE, Jenkinson H, Moll A, Munier FL, Popovic MB, Chantada G, Doz F and Ketteler P.

    Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG).

    PEDIATRIC BLOOD & CANCER . 68(6): . Nº de cites: 13

    [doi:10.1002/pbc.28963]

  • Ferretti R, Baldassarre A, Billy E, Carcaboso AM, Moore A, Carai A, Mastronuzzi A, Masotti A and Vinci M.

    Tumor cell invasion into Matrigel: optimized protocol for RNA extraction

    Biotechniques . : 327-335. Nº de cites: 2

    [doi:10.2144/btn-2021-0001]